✦ LIBER ✦

Clinical study of recovery and half-life of vapor-heated factor VII concentrate

✍ Scribed by G. E. Rivard; I. Kovac; M. Kunschak; P. M. Thöne; Factor VII Study Group

Book ID: 114439700
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 384 KB
Volume: 34
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1994.341195065036.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HALF-LIFE AND IN-VIVO RECOVERY OF HEATED

HALF-LIFE AND IN-VIVO RECOVERY OF HEATED FACTOR VIII CONCENTRATES

✍ Morfini, M.; Messori, A.; Longo, G.; Cinotti, S.; Matucci, M.; Ferrini, P.Rossi 📂 Article 📅 1986 🏛 The Lancet 🌐 English ⚖ 310 KB

Comparison of the recovery and half-life

Comparison of the recovery and half-life of a high-purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study Group

✍ M. -C. Poon; L. M. Aledort; K. Anderle; M. Kunschak; M. Morfini; The Factor IX S 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Prophylaxis and therapy with factor VII

Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports

✍ Lewis J. Cohen; Nancy B. McWilliams; Ronnie Neuberg; William Zinkham; Kenneth Ba 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

M.D.P.); and lmmuno A.G., Vienna, Austria (M.K.) Hereditary factor VII deficiency is a rare autosomal recessive condition, usually associated with normal or reduced levels of a functionally defective molecule. The available means of treating thiscondition in North America presents serious health ri

Factor VII Half-life after Transfusion o

Factor VII Half-life after Transfusion of a Steam-treated Prothrombin Complex Concentrate in a Patient with Homozygous Factor VII Deficiency

✍ Michael Köhler; Peter Hellstern; Gerhard Pindur; Ernst Wenzel; Gerhard von Blohn 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Low risk of viral infection after admini

Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group

✍ A. Shapiro; T. Abe; L. M. Aledort; K. Anderle; M. W. Hilgartner; M. Kunschak; F. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 500 KB

In vivo recovery and half-life time of a

In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients

✍ K�hler, M. ;Seifried, E. ;Hellstern, P. ;Pindur, G. ;Miyashita, C. ;M�rsdorf, S. 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 520 KB

Factor IX (FIX) recovery and half-life was measured in ten hemophilia B patients under standardized conditions. Each patient received a steam-treated high-purity factor IX concentrate at a dose of 19-39 U/kg body weight. FIX activity was determined using a one-stage assay, which was calibrated again